GrantsFeed
Grants & Funding

Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren vs Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-11

Side-by-side comparison of two grants.

AttributeGermany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-VerfahrenGermany – Pharmaceutical products – Open-House-Rabattverträge 2024-11
TypeTenderTender
Funding amount——
DeadlineCloses 2028-07-05Closes 2028-10-31
RegionDEUDEU
SectorHealthHealth
FunderIKK classicTechniker Krankenkasse
Who it's for——

noindex — no measured search demand